MedKoo Cat#: 585350 | Name: Streptovarycin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Streptovarycin is a complex of ansamycin antibiotics consisting of streptovaricins A, B, C, D, E, F, G, J, and K of which streptovaricin C is the major component. (From Merck Index, 11th ed)

Chemical Structure

Streptovarycin
Streptovarycin
CAS#1404-74-6

Theoretical Analysis

MedKoo Cat#: 585350

Name: Streptovarycin

CAS#: 1404-74-6

Chemical Formula: C40H51NO14

Exact Mass: 769.3310

Molecular Weight: 769.84

Elemental Analysis: C, 62.41; H, 6.68; N, 1.82; O, 29.10

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Streptovarycin; U 7750; U-7750; U7750
IUPAC/Chemical Name
methyl (7E,9Z,11R,13R,14R,15R,16R,17R,18R,19R,20E)-2-acetyloxy-12,14,16,18,19,31-hexahydroxy-3,7,11,13,17,19,21,27-octamethyl-6,28-dioxo-23,25-dioxa-5-azatetracyclo[20.7.1.14,29.026,30]hentriaconta-1,3,7,9,20,22(30),26,29(31)-octaene-15-carboxylate
InChi Key
JDECNKBYILMOLE-UTNWNAHBSA-N
InChi Code
InChI=1S/C40H51NO14/c1-16-12-11-13-17(2)38(49)41-28-19(4)36(55-23(8)42)24-25(33(28)47)31(45)21(6)35-26(24)34(53-15-54-35)18(3)14-40(9,51)37(48)22(7)32(46)27(39(50)52-10)30(44)20(5)29(16)43/h11-14,16,20,22,27,29-30,32,37,43-44,46-48,51H,15H2,1-10H3,(H,41,49)/b12-11-,17-13+,18-14+/t16-,20-,22-,27-,29?,30-,32-,37-,40-/m1/s1
SMILES Code
O=C([C@@H]([C@H](O)[C@@H](C)[C@@H](O)[C@](C)(O)/C=C(C)/C(OCO1)=C2C1=C(C)C3=O)[C@H](O)[C@H](C)C(O)[C@H](C)/C=C\C=C(C)\C(NC4=C(C)C(OC(C)=O)=C2C3=C4O)=O)OC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 769.84 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Liu Y, Chen X, Li Z, Xu W, Tao W, Wu J, Yang J, Deng Z, Sun Y. Functional Analysis of Cytochrome P450s Involved in Streptovaricin Biosynthesis and Generation of Anti-MRSA Analogues. ACS Chem Biol. 2017 Oct 20;12(10):2589-2597. doi: 10.1021/acschembio.7b00467. Epub 2017 Sep 7. PubMed PMID: 28858479. 2: Wang G, Zhang H, Sun G, Wu L, Zhang J, Wang Y. A new method for rapid identification of ansamycin compounds by inactivating KLM gene clusters in potential ansamycin-producing actinomyces. J Appl Microbiol. 2012 Feb;112(2):353-62. doi: 10.1111/j.1365-2672.2011.05206.x. Epub 2012 Jan 3. PubMed PMID: 22129076. 3: Sánchez-Hidalgo M, Núñez LE, Méndez C, Salas JA. Involvement of the beta subunit of RNA polymerase in resistance to streptolydigin and streptovaricin in the producer organisms Streptomyces lydicus and Streptomyces spectabilis. Antimicrob Agents Chemother. 2010 May;54(5):1684-92. doi: 10.1128/AAC.01406-09. Epub 2010 Feb 22. PubMed PMID: 20176899; PubMed Central PMCID: PMC2863669. 4: Torres W, Rodríguez RR, Prieto JA. Stereoselective construction of all-anti polypropionate modules: synthesis of the C5-C10 fragment of streptovaricin U. J Org Chem. 2009 Mar 20;74(6):2447-51. doi: 10.1021/jo8026966. PubMed PMID: 19236033; PubMed Central PMCID: PMC2677810. 5: Sarabia F, Sánchez-Ruiz A, Martín-Ortiz L, García-Castro M, Chammaa S. Stereoselective synthesis of macrolide-type antibiotics from epoxy amides. Synthesis of the polypropionate chain of streptovaricin u. Org Lett. 2007 Nov 22;9(24):5091-4. Epub 2007 Nov 2. PubMed PMID: 17975922. 6: Rodríguez D, Mulero M, Prieto JA. Highly regioselective copper-catalyzed cis- and trans-1-propenyl Grignard cleavage of hindered epoxides. application in propionate synthesis. J Org Chem. 2006 Jul 21;71(15):5826-9. PubMed PMID: 16839177. 7: Ooka K, Tanaka M, Ishikawa T, Kato F. An antimutagenic metabolite, streptovaricin C, isolated from Streptomyces sp. Biol Pharm Bull. 1999 Jan;22(1):107-10. PubMed PMID: 9989675. 8: Spasova D, Vesselinova N, Gesheva R. Comparative investigation of a streptovaricin-producing strain of Streptomyces spectabilis and its selectant. Folia Microbiol (Praha). 1997;42(1):35-8. PubMed PMID: 9206681. 9: Yu Q, Fan C. [Taxonomy of 1043 strain producing actinospectacin]. Wei Sheng Wu Xue Bao. 1994 Apr;34(2):160-3. Chinese. PubMed PMID: 8073763. 10: Staley AL, Rinehart KL. Biosynthesis of the streptovaricins: 3-amino-5-hydroxybenzoic acid as a precursor to the meta-C7N unit. J Antibiot (Tokyo). 1991 Feb;44(2):218-24. PubMed PMID: 1672686. 11: Vesselinova N, Gesheva R, Ivanova V. Streptomyces species producing the streptovaricin complex. Folia Microbiol (Praha). 1991;36(6):538-41. PubMed PMID: 1688164. 12: Klimpel KW, Clark VL. The RNA polymerases of Porphyromonas gingivalis and Fusobacterium nucleatum are unrelated to the RNA polymerase of Escherichia coli. J Dent Res. 1990 Sep;69(9):1567-72. PubMed PMID: 2204641. 13: Ito S, Gilljams G, Wahren B, Wigzell H, Yamamoto N, Sasaki K, Onodera K. Inhibition of HIV replication by 19-O-n-pentyldamavaricin Fc in vitro. J Antibiot (Tokyo). 1990 Aug;43(8):1045-6. PubMed PMID: 1976616. 14: Logan K, Zhang J, Davis EA, Ackerman S. Drug inhibitors of RNA polymerase II transcription. DNA. 1989 Oct;8(8):595-604. PubMed PMID: 2574659. 15: Ito S, Yamamoto N, Nomoto K, Sasaki K, Onodera K. Selective killing of human T cell lymphotropic virus type I-transformed cell lines by a damavaricin Fc derivative. J Antibiot (Tokyo). 1989 May;42(5):779-87. PubMed PMID: 2566592. 16: Onodera K, Ito S, Sasaki K. Biological activity of damavaricin derivatives. Subcell Biochem. 1989;15:69-90. Review. PubMed PMID: 2572077. 17: Laffan JJ, Firshein W. Origin-specific DNA-binding membrane-associated protein may be involved in repression of initiation of DNA replication in Bacillus subtilis. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7452-6. PubMed PMID: 3140241; PubMed Central PMCID: PMC282209. 18: Logan K, Ackerman S. Effects of antibiotics on RNA polymerase III transcription. DNA. 1988 Sep;7(7):483-91. PubMed PMID: 2905235. 19: Laffan J, Firshein W. DNA replication by a DNA-membrane complex extracted from Bacillus subtilis: site of initiation in vitro and initiation potential of subcomplexes. J Bacteriol. 1987 Jun;169(6):2819-27. PubMed PMID: 2884211; PubMed Central PMCID: PMC212191. 20: Ivanova V, Vesselinova N, Gesheva R, Naidenova M. Comparative investigation of the components of antibiotic complex 1011 with thin-layer chromatography of variants from Streptomyces sp. 1000. Acta Microbiol Bulg. 1987;21:52-6. PubMed PMID: 2894113.